Discover the Secret Ingredients Behind OxyElite Pro's Massive Weight Loss Success!

USP Labs has become known for their innovation, dedication, and perfection of premium-grade herbal extracts that cannot be found anywhere else. And OxyELITE Pro is no exception.

When formulating OxyELITE Pro, USP Labs asked a very simple question. "Why is the last place to lose fat, the FIRST place to gain it?"

The Alpha 2-Receptor

After careful research, USP Labs discovered that body fat is quite literally held "hostage" by a receptor called the Alpha 2-receptor. And when it comes to losing weight, the Alpha 2-receptor is your absolute worst nightmare. Here's why.

When the Alpha 2-receptor wants you to store fat, you're going to store fat, and you're going to store lots of it in all of your worst trouble spots. That's because the Alpha 2-receptor is heavily concentrated in areas such as your stomach, hips, buttocks, and neck.

You see, the Alpha 2-receptor is responsible for stopping the break down the body fat. And when this receptor is activated, your "trouble spot" areas are practically in lock down. What that means is not only are you unable to release body fat to be burnt, but your body is now being told to store MORE fat.

Thankfully, this is where OxyELITE Pro shines, as scientists have identified a key ingredient that specifically targets, blocks, and turns off the alpha 2-receptor!

The OxyELITE Pro Ingredient Line Up

View OxyELITE Pro Supplement Facts

Rauwolfia Canescens (Rauwolscine)

This super ingredient is suggested to block and shut down the Alpha-2 receptor.

Rauwolscine is related to yohimbine, a popular ingredient found in many thermogenic products due to its ability to work against (antagonize) Alpha 2-receptors.

But there's a BIG problem with yohimbine. Not only does it work against the Alpha 2-receptors, it also works against the Alpha 1-receptors. And that's not good because a compound that works against the Alpha 1-receptors may actually inhibit fat loss.

So the same compound that may help improve fat breakdown, may also prevent fat breakdown too. It's kind of like taking one step forward, and one step back, or hitting the gas pedal and breaks on a car at the same time. The end result to you is a small if barely noticeable affect on fat loss, which is what's suggested in some of the literature with yohimbine use (14-17).

And this is why Rauwolscine is included in the OxyELITE Pro line up. It may be equally effective as yohimbine at working against your Alpha 2-receptors (great for fat loss), while having minimal effect on your Alpha 1-receptors (even better for fat loss)!

The Low Down on T3 and T4 Thyroid hormone

To understand how the next two ingredients in OxyELITE Pro work, we need to take a moment and discuss thyroid hormones. This part is really cool!

Have you ever heard someone say the reason they can't lose weight is because of their thyroid? It is very common today, as we know the thyroid plays a very important roll in regulating metabolic rate.

The two important thyroid hormones...when it comes to fat loss...are Thyroxine (T4) and Triiodothyronine (T3). T4 converts into T3, with T4 being roughly 20x more prevalent in your blood stream than T3. And while T3 may not have been Arnold's shining moment at the box office, it is certainly the star in your bloodstream when it comes to full fledged thermogenesis.

Now, T3 thryoid hormone is is about three to four times more powerful than T4. It increases your body's metabolism, increases protein synthesis (great for preserving lean muscle while losing fat), decreases the effects of fat-storing insulin, and may even put you in a better mood by increasing levels of serotonin in the brain.

So naturally we want to help the body product more T4 and T3 thryoid hormone, and USP Labs has included two ingredients that may do just that!

Bauhinia purpurea L. [Leaf & Pod (standardized for Bauhiniastatins 1-4)]

Bauhinia purpurea L. is a very exciting because in healthy adult animal models, it has been suggested to increase T4 thyroid hormone while also increasing T3 thyroid hormone by an astonishing 83% (21)!

And, increasing thyroid hormone levels is believed to increase the fat breakdown effects achieved from adrenergic stimulation in fat cells (33). This has lead the authors to believe that Bauhinia purpurea L. is likely increasing the conversion of peripheral T4 into T3 thyroid hormone....and we want more T3!

Bacopa monnieri (Leaf)

Similar to Bauhinia purpurea L., Bacopa monnieri, in an animal model, is also suggested to naturally promote production of T4 thryoid hormone when compared to controls (23). In this case, the authors concluded that Bacopa monnieri can help increase the release of T4 thyroid hormone.

Now, this is certainly interesting, because what USP Labs has done is include one ingredient that increases the release of T4, and another ingredient () that increases the conversion of T4 into T3. So this may in fact be dramatically ramping up the release of T3 thyroid hormone into your body, which is certainly indicative of the intense heat people feel from the OxyELITE Pro formula.

Geranium [Stems](extracted for 1,3-Dimethylamylamine)

Used for centuries as a food additive, Geranium contains a powerful constituent known as 1,3-Dimethylamylamine. The 1,3-Dimethylamylamine found inside acts as a super stimulant that resembles your body's own chemical messenger, epinephrine...also known as adrenaline.

Cirsium Oligophyllum (Whole Plant Extract)

USP Labs included yet another very unique and exciting plant extract that, in animal models, helped to greatly reduce body weight gain and fat mass, while specifically targeting subcutaneous fat mass over visceral fat mass.

Subcutaneous...visceral....what? I'll explain. Your body actually has two types of fat. The first is subcutaneous fat, which is the fat that covers your muscles and makes you look smooth, soft, and pudgy. THIS is the fat we want to get rid of.

Visceral fat mass is the fat that encases and protects your organs. And while losing visceral fat mass is certainly healthy for obese individuals, it's not going to result in a lean six pack. And unfortunately, all too often companies include ingredients that don't make a distinction between subcutaneous and visceral fat mass. But USP Labs has paid very careful attention to the ingredients chosen for OxyELITE Pro to ensure that you're losing the right kind of fat in precisely the areas you want to.

Ok, back to Cirsium Oligophyllum! This extract is also suggested to have a powerful synergistic effect with caffeine and potentially produce a far greater lypolitic effect. In fact, when Cirsium Oligophyllum and caffeine were combined, the potency was almost 10 times greater when compared to the effects of Cirsium Oligophyllum alone!

Caffeine

The last ingredient in USP Lab's OxyELITE Pro is caffeine. Now, we all know that every company includes caffeine in their formula. After all, caffeine is known for it's ability increase resting energy expenditure, the break down of body fat, and lipid oxidation (6-8). Caffeine is also known to increase mental alertness, concentration, feelings of energy, and euphoria (9-10). Nice, right!

But USP Labs included caffeine for a very specific purpose as noted above. Caffeine has powerful synergistic effects with other ingredients in the OxyELITE Pro formula...specifically Cirsium Oligophyllum!

References

  1. Anonymous. New and nonofficial remedies: methylhexamine; forthane. J Am Med Assoc. 1950 Jul 29;143(13):1156
  2. Swanson EE and Chen KK. Comparison of pressor action of aliphatic amines. J Pharmacol Exp Ther. 1946 88(1):10-13
  3. Charlier R. Pharmacology of 2-amino-4-methylhexane. Private Trans. Arch Int Pharmacodyn Ther. 1950 Sep 1;83(4):573-584
  4. Diepvens K, Westerterp KR, Westerterp-Plantenga MS. Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea. Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R77-85
  5. Mori S, Satou M, Kanazawa S, et al. Body fat mass reduction and up-regulation of uncoupling protein by novel lipolysis-promoting plant extract. Int J Biol Sci 2009;5(4):311-318
  6. Bracco D, Ferrarra JM, Arnaud MJ, et al. Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women. Am J Physiol. 1995 Oct;269(4 Pt 1):E671-E678
  7. Dullo AG, Geissler CA, Horton T, et al. Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers. Am J Clin Nutr. 1989 Jan;49(1):44-50
  8. Acheson KJ, Gremaud G, Meirim I, et al. Metabolic effects of caffeine in humans: lipid oxidation or futile cycling? Am J Clin Nutr. 2004 Jan;79(1):40-46
  9. Kaplan GB, Greenblatt DJ, Ehrenberg BL, et al. Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. J Clin Pharmacol. 1997 Aug;37(8):693-703
  10. Smith A. Effects of caffeine on human behavior. Food Chem Toxicol. 2002 Sep;40(9):1243-1255
  11. Berlan M, Galitzky J, Riviere D, et al. Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and non-obese women. Int J Obes. 1991 May;15(5):305-315
  12. Galitzky J, Taouis M, Berlan M, et al. Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers. Eur J Clin Invest. 1988 Dec;18(6):587-594
  13. Flechtner-Mors M, Jenkinson CP, Alt A, et al. In vivo alpha(1)-adrenergic lipolytic activity in subcutaneous adipose tissue of obese subjects. J Pharmacol Exp Ther. 2002 Apr;301(1):229-233
  14. Sax L. Yohimbine does not affect fat distribution in men. Int J Obes. 1991 Sep;15(9):561-565
  15. Kucio C, Jonderko K, Piskorska D. Does yohimbine act as a slimming drug? Isr J Med Sci. 1991 Oct;27(10):550-556
  16. Berlin I, Stalla-Bourdillon A, Thuillier Y, et al. Lack of efficacy of yohimbine in the treatment of obesity. J Pharmacol. 1986 Jul-Sep;17(3):343-347
  17. Zahorska-Markiewicz B, Kucio C, et al. Adrenergic control of lipolysis and metabolic responses in obesity. Horm Metab Res. 1986 Oct;18(10):693-697
  18. Perry BD, U'Prichard DC. [3H]rauwolscine (alpha-yohimbine): a specific antagonist radioligand for brain alpha 2-adrenergic receptors. Eur J Pharmacol. 1981 Dec 17;76(4):461-464
  19. Berlan M, Le Verge R, Galitzky J, et al. Alpha 2-adrenoceptor antagonist potencies of two hydroxylated metabolites of yohimbine. Br J Pharmacol. 1993 Apr;108(4):927-932
  20. Kronenberg HM, Melmed S, Polonsky KS, Larsen PR.: Williams Textbook of Endocrinology, 11th ed., Saunders Elsevier, Philadelpha, PA, 2008.
  21. Panda S, Kar A. Withania somnifera and Bauhinia purpurea in the regulation of circulating thyroid hormone concentrations in female mice. J Ethnopharmacol. 1999 Nov 1;67(2):233-239
  22. Jatwa R, Kar A. Amelioration of metformin-induced hypothyroidism by Withania somnifera and Bauhinia purpurea extracts in Type 2 diabetic mice. Phytother Res. 2009 Aug;23(8):1140-1145
  23. Kar A, Panda S, Bharti S. Relative efficacy of three medicinal plant extracts in the alteration of thyroid hormone concentrations in male mice. J Ethnopharmacol. 2002 Jul;81(2):281-285
  24. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, et al. Cold-activated brown adipose tissue in healthy men. N Engl J Med. 2009 Apr 9;360(15):1500-1508
  25. Fruhbeck G, Becerril S, Sainz N, et al. BAT: a new target for human obesity? Trends Pharmacol Sci 2009 Aug;30(8):387-396
  26. Cypress AM, Lehman S, Williams G, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med. 2009 Apr 9;360(15):1509-1517
  27. Virtanen KA, Lidell ME, Orava J, et al. Functional brown adipose tissue in healthy adults. N Engl J Med. 2009 Apr 9;360(15):1518-1525
  28. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev. 2004 Jan;84(1):277-359
  29. Celi FS. Brown adipose tissue—when it pays to be inefficient. N Engl J Med. 2009 Apr 9;360(15):1553-1556
  30. Robertson D, Frolich JC, Carr RK, et al. Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med. 1978 Jan 26;298(4):181-186
  31. Silva JE, Larsen PR. Adrenergic activation of triiodothyronine production in brown adipose tissue. Nature. 1983 Oct 20-26;305(5936):712-713
  32. Raasmaja A, York DA. Pharmacological characterization of alpha1- and beta-adrenergic synergism of 5'DII activity in rat brown adipocytes. Arch Physiol Biochem. 2006 Feb;112(1):23-30
  33. Hellstrom L, Wahrenberg H, Reynisdottir S, et al. Catecholamine-induced adipocyte lipolysis in human hyperthyroidism. J Clin Endocrinol Metab. 1997 Jan;82(1):159-166
  34. Neylon CB, Summers RJ. [3H]-rauwolscine binding to alpha 2-adrenoceptors in the mammalian kidney: apparent receptor heterogeneity between species. Br J Pharmacol. 1985 June;85(2):349-359

Note: This website is not run by or affiliated with USPLabs, LLC. To visit USP Labs' official website, please go to USPLabsDirect.com. Please note that none of the statements made on this website are approved or endorsed by USPlabs LLC. All statements are the sole property of this site's owners.

This website is also not intended to assist USP Labs, LLC in their marketing, sales, or distribution of dietary supplements. It is intended for entertainment purposes only. The owners and operators of this website are not employed by, nor are they affiliated with USP Labs, LLC in any fashion. The owners and operators of this website also do not receive any compensation from USP Labs, LLC.

The statements made on this website are not approved by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Before using this product or any dietary supplement, please contact your qualified health care physician.